オリーブ葉成分によるヒト白血病細胞および造血幹細胞の分化誘導特性 by Imen SAMET
Differentiation Induction of Human Leukemia
Cells and Normal Hematopoietic Stem Cells by
Olive Leaf Extract Components
著者 Imen SAMET
内容記述 この博士論文は内容の要約のみの公開（または一部
非公開）になっています
year 2015
その他のタイトル オリーブ葉成分によるヒト白血病細胞および造血幹
細胞の分化誘導特性
学位授与大学 筑波大学 (University of Tsukuba)
学位授与年度 2014
報告番号 12102乙第2719号
URL http://hdl.handle.net/2241/00129537
  
Differentiation Induction of Human Leukemia Cells and Normal 
Hematopoietic Stem Cells by Olive Leaf Extract Components 
 
 
 
 
 
A Dissertation Submitted to 
Graduate School of Life and Environmental Sciences,  
the University of Tsukuba 
In Partial Fulfillment of the Requirements 
For The Degree of Doctor of Philosophy  
(Doctoral Program in Biosphere Resource Science and Technology) 
 
 
 
 
 
Imen SAMET 
 
 
Abstract 
 
With the major problems associated with the use of chemotherapy for leukemia treatment, 
new approaches have been developed during the last three decades. Based on the concept that 
leukemia cells result from a blockade in the process of maturation, the differentiation-inducing 
therapy has anticipated as a novel medical treatment aiming to induce leukemia cells to resume 
the process of differentiation and enter the apoptotic pathways. Even though some success has 
been made over the past years, problems such side effects during the long term use as well as 
development of resistance to known differentiation inducers continue to limit this approach. To 
face these obstacles, transplantation of hematopoietic stem cells (HSCs) and the transfusion of 
the blood cellular components have been recently come into clinical use and have been shown to 
be a life-saving procedure in a broad spectrum of hematological diseases. Thus, strategies to 
expand either hematopoietic progenitors (CD34+ cells) or the selected subpopulations have been 
an area of active research. This study was launched in an attempt to help the development of new 
differentiation-inducing agents from olive leaf. Furthermore, the author tried to raise approach 
for the possible use of phytochemicals from olive leaf as supplement to the ex-vivo culture of 
HSCs in order to direct the stem cell fate decision.  
Olive leaves collected from different cultivars of the most abundant Tunisian variety, 
Chemlali, were screened for their anti-leukemia effects on chronic myelogenous leukemia K562 
cells. Ethanol extract of olive leaf from Chemlali Sfax showed the best anti-proliferative effect 
and was chosen for further study. Results indicated that treatment with Chemlali Olive Leaf 
Extract (COLE) inhibits the growth rate of K562 cells and caused an arrest of the cell cycle. 
Further investigations revealed that COLE induces apoptosis and differentiation of K562 cells 
toward monocyte/macrophage lineage. Microarray analysis was conducted in order to understand 
the mechanism involved in the described effects. The differentially expressed genes such as 
IFI16, EGR1, NFYA, FOXP1, CXCL2, CXCL3 and CXCL8 confirmed the commitment of K562 
cells to the monocyte/macrophage lineage. Consistently with the increase in apoptotic cell 
number, treatment with COLE up-regulated some pro-apoptotic genes such as CASP6, CASP8, 
DFFA and BID and down-regulated the apoptosis suppressor gene BCL2 and the caspase 
inhibitors. A proposed mechanism for the differentiation and apoptosis-induced effects of COLE, 
involves a cross-talk between the JNK pathway and the NF-kappaB pathway.  
In the second part of our work, olive leaf main phytochemicals were investigated for their 
potential differentiation-inducing effects on HSCs. Results showed that the main compounds of 
olive leaf extract, Oleuropein (Olp), Apigenin 7-glucoside (Api7G) and Luteolin 7-glucoside 
(Lut7G), used alone or in combination, have the potential to induce the differentiation of HSCs 
into different types of blood cells. The combination of the three compounds enhances the 
myelomonocytic and lymphoid differentiation while inhibiting the commitment to 
megakaryocytic and erythrocytic lineages. This effect is likely to be attributed to the 
combination’s major compound Olp. Microarray analysis results showed an up-regulation of 
genes related to Wnt signaling pathway (FZD5, FZD3), Notch pathway (NOTCH2, MFNG, 
APH1B) and TGF-beta pathway (TGFBR2, SMAD4). An up-regulation of genes related to 
differentiation of lymphocytes B and T was also detected, as well as genes of cell adhesion, 
motility and membrane trafficking (CD46, MEF2C, CD58, NAMPT, etc.). Api7G induced the 
differentiation of CD34+ cells towards the erythrocytes and megakaryocytes lineages and 
inhibited the myeloid differentiation, while Lut7G stimulated both the erythroid and the myeloid 
differentiation. Erythroid differentiation induced by Api7G and Lut7G treatments was confirmed 
by the increased levels of hemoglobin genes expression (α-hemoglobin, β-hemoglobin and γ-
hemoglobin) and erythroid transcription factor GATA1 expression, as well as by the increase in 
the number of BFU-E and CFU-GEMM in methylcellulose cultures.  
Taken together, these findings provide evidence of the differentiation-inducing effects of 
olive leaf extract and its components on both leukemia cells and normal hematopoietic stem 
cells. These findings could help designing approaches for the development of diet-derived 
therapeutic agents against cancer. Moreover, having such effect on hematopoietic stem cells 
suggests that olive leaf phytochemicals may be used in the development of strategies for 
stimulating the endogenous stem cells in the adult to promote healing and regenerative medicine. 
Furthermore, the described properties highlight their potential use in optimizing the ex vivo 
generation of the selected hematopoietic sub-populations for infusion purposes. 
 
